DK1569961T3 - Splice variant af det menneskelige hypofysevæksthormon - Google Patents

Splice variant af det menneskelige hypofysevæksthormon

Info

Publication number: DK1569961T3
Authority: DK; Denmark
Prior art keywords: growth hormone; splice variant; human pituitary; pituitary growth; protein
Prior art date: 2002-12-05

Application number

DK03778588.8T

Other languages

English (en)

Inventor

Tiani Mariastella De

Richard Joseph Fagan

Christopher Benjamin Phelps

Tania Maria Rodrigues

Melanie Yorke-Smith

Original Assignee

Ares Trading Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-05

Filing date

2003-12-05

Publication date

2010-04-12

2003-12-05 Application filed by Ares Trading Sa filed Critical Ares Trading Sa

2010-04-12 Application granted granted Critical

2010-04-12 Publication of DK1569961T3 publication Critical patent/DK1569961T3/da

Links

101000664737 Homo sapiens Somatotropin Proteins 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 3
102000004169 proteins and genes Human genes 0.000 abstract 2
238000003745 diagnosis Methods 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
150000007523 nucleic acids Chemical group 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Oncology (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Virology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Zoology (AREA)

DK03778588.8T 2002-12-05 2003-12-05 Splice variant af det menneskelige hypofysevæksthormon DK1569961T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0228441.2A GB0228441D0 (en)	2002-12-05	2002-12-05	Splice variant
PCT/GB2003/005295 WO2004050703A1 (en)	2002-12-05	2003-12-05	Splice variant of the human pituitary growth hormone

Publications (1)

Publication Number	Publication Date
DK1569961T3 true DK1569961T3 (da)	2010-04-12

Family

ID=9949159

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK03778588.8T DK1569961T3 (da)	2002-12-05	2003-12-05	Splice variant af det menneskelige hypofysevæksthormon

Country Status (13)

Country	Link
US (1)	US7531508B2 (da)
EP (1)	EP1569961B1 (da)
JP (1)	JP2006525782A (da)
AT (1)	ATE456576T1 (da)
AU (1)	AU2003285589B2 (da)
CA (1)	CA2507631A1 (da)
DE (1)	DE60331166D1 (da)
DK (1)	DK1569961T3 (da)
ES (1)	ES2338317T3 (da)
GB (1)	GB0228441D0 (da)
NO (1)	NO20052525L (da)
PT (1)	PT1569961E (da)
WO (1)	WO2004050703A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20140087964A1 (en) *	2012-09-24	2014-03-27	University Of Virginia Patent Foundation	Compositions and methods for detecting aberrant regulation, expression, and levels of hgh
CA3018328A1 (en)	2014-10-31	2016-04-30	Purdue Pharma	Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en)	2018-11-19	2020-07-28	Purdue Pharma L.P.	Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100236393B1 (ko) *	1996-02-02	1999-12-15	나까니시 히로유끼	사람성장호르몬을 함유하는 의약제제
FR2786104B1 (fr) *	1998-11-25	2002-12-27	Centre Nat Rech Scient	Inhibiteurs de l'activation de nf-kb, et leurs utilisations pharmaceutiques

2002
- 2002-12-05 GB GBGB0228441.2A patent/GB0228441D0/en not_active Ceased
2003
- 2003-12-05 EP EP03778588A patent/EP1569961B1/en not_active Expired - Lifetime
- 2003-12-05 DE DE60331166T patent/DE60331166D1/de not_active Expired - Lifetime
- 2003-12-05 AT AT03778588T patent/ATE456576T1/de active
- 2003-12-05 PT PT03778588T patent/PT1569961E/pt unknown
- 2003-12-05 ES ES03778588T patent/ES2338317T3/es not_active Expired - Lifetime
- 2003-12-05 JP JP2004556543A patent/JP2006525782A/ja active Pending
- 2003-12-05 DK DK03778588.8T patent/DK1569961T3/da active
- 2003-12-05 AU AU2003285589A patent/AU2003285589B2/en not_active Ceased
- 2003-12-05 WO PCT/GB2003/005295 patent/WO2004050703A1/en not_active Ceased
- 2003-12-05 CA CA002507631A patent/CA2507631A1/en not_active Abandoned
- 2003-12-05 US US10/537,142 patent/US7531508B2/en not_active Expired - Fee Related
2005
- 2005-05-26 NO NO20052525A patent/NO20052525L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US20060275293A1 (en)	2006-12-07
EP1569961A1 (en)	2005-09-07
NO20052525D0 (no)	2005-05-26
US7531508B2 (en)	2009-05-12
WO2004050703A1 (en)	2004-06-17
DE60331166D1 (de)	2010-03-18
AU2003285589B2 (en)	2010-07-08
AU2003285589A1 (en)	2004-06-23
ATE456576T1 (de)	2010-02-15
PT1569961E (pt)	2010-02-05
NO20052525L (no)	2005-08-16
GB0228441D0 (en)	2003-01-08
JP2006525782A (ja)	2006-11-16
EP1569961B1 (en)	2010-01-27
CA2507631A1 (en)	2004-06-17
WO2004050703A8 (en)	2004-09-23
ES2338317T3 (es)	2010-05-06

Publication	Publication Date	Title
CY1107146T1 (el)	2012-05-23	Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
WO2004076614A3 (de)	2005-08-18	Humane nukleinsäuresequenzen aus prostatakarzinomen
WO2004096856A3 (en)	2005-03-17	Secreted protein family
ATE482976T1 (de)	2010-10-15	Defensinproteine
NO20070780L (no)	2007-05-11	Celloverflateprotein.
ATE533779T1 (de)	2011-12-15	Isoliertes photoprotein mtclytin, sowie dessen verwendung
NO20052525D0 (no)	2005-05-26	Spleisevariant av humant hypofyseveksthormon
DE50308032D1 (de)	2007-10-04	Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
MXPA05009954A (es)	2005-11-04	Familia de proteinas secretadas.
WO2004053117A3 (en)	2004-09-23	Serine protease
ATE526400T1 (de)	2011-10-15	Metalloproteaseproteine
WO2004056863A8 (en)	2004-09-30	Splice variant of human placental growth hormone
EA200501843A1 (ru)	2006-06-30	Tnf-подобный секретируемый белок
DE60129228D1 (de)	2007-08-16	Humane 7-transmembranproteine und dafür codierende polynukleotide
WO2004026905A3 (en)	2004-09-16	Transporter/channel proteins
WO2004000882A3 (en)	2004-03-11	Proteins
WO2004003011A3 (en)	2004-03-25	Nuclear hormone receptor
WO2002062845A3 (en)	2003-03-06	Adhesion molecules
WO2002044382A8 (en)	2002-07-18	Cytokine-like proteins
WO2004016654A8 (en)	2004-04-29	Il-8 like protein
WO2004024762A3 (en)	2004-05-27	Il-8 like protein
WO2004035626A3 (en)	2004-10-07	Alpha macroglobulin protein family members
WO2002050116A3 (en)	2002-11-14	Adhesion molecule protein